Albiglutide approved for type 2 diabetes.
Kate
K
Traynor
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D017277:Drug Approval; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage / Q000819:agonists / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; C534611:rGLP-1 protein; D052216:Glucagon-Like Peptide 1